$CBRG
Chain Bridge I

2022 Q4 Form 10-K Financial Statement

#000110465923033841 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $467.6K $1.394M
YoY Change 212.06% 537.58%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $467.6K $1.394M
YoY Change 212.06% 537.58%
Operating Profit -$1.394M
YoY Change
Interest Expense $2.882M $12.13M
YoY Change -45.95% 127.51%
% of Operating Profit
Other Income/Expense, Net -$61.76K -$27.99K
YoY Change -60.77% -82.22%
Pretax Income $2.353M $10.71M
YoY Change -53.18% 116.08%
Income Tax
% Of Pretax Income
Net Earnings $2.353M $10.71M
YoY Change -53.18% 116.08%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.08 $0.37
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.3K $116.3K
YoY Change -84.29% -84.29%
Cash & Equivalents $116.3K
Short-Term Investments
Other Short-Term Assets $322.3K $322.3K
YoY Change -60.99% -60.99%
Inventory
Prepaid Expenses $322.3K
Receivables
Other Receivables
Total Short-Term Assets $438.6K $438.6K
YoY Change -72.01% -72.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $237.8M $237.8M
YoY Change 1.35% 1.35%
Other Assets
YoY Change
Total Long-Term Assets $237.8M $237.8M
YoY Change 1.35% 1.35%
TOTAL ASSETS
Total Short-Term Assets $438.6K $438.6K
Total Long-Term Assets $237.8M $237.8M
Total Assets $238.2M $238.2M
YoY Change 0.87% 0.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.06K $27.06K
YoY Change
Accrued Expenses $5.433K $5.430K
YoY Change -95.33% -95.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.49K $32.49K
YoY Change -72.07% -72.07%
LONG-TERM LIABILITIES
Long-Term Debt $1.432M $1.432M
YoY Change 35.88% 35.88%
Other Long-Term Liabilities $2.815M $2.815M
YoY Change -76.08% -76.08%
Total Long-Term Liabilities $4.246M $4.246M
YoY Change -66.88% -66.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.49K $32.49K
Total Long-Term Liabilities $4.246M $4.246M
Total Liabilities $4.279M $4.279M
YoY Change -66.93% -66.93%
SHAREHOLDERS EQUITY
Retained Earnings -$3.741M
YoY Change -67.05%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.740M $234.0M
YoY Change
Total Liabilities & Shareholders Equity $238.2M $238.2M
YoY Change 0.87% 0.87%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $2.353M $10.71M
YoY Change -53.18% 116.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$210.4K -$904.3K
YoY Change -75.77% 4.13%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 280.0K 280.0K
YoY Change -99.88% -99.88%
NET CHANGE
Cash From Operating Activities -210.4K -904.3K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 280.0K 280.0K
Net Change In Cash 69.63K -624.3K
YoY Change -90.55% -184.29%
FREE CASH FLOW
Cash From Operating Activities -$210.4K -$904.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001845149
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 CBRGU Transition Report
TransitionReport
true
CY2022 CBRGU Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41047
CY2022 dei Entity Registrant Name
EntityRegistrantName
Chain Bridge I
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
KY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-1578955
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
330 Primrose Road, Suite 500
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Burlingame
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94010
CY2022 dei City Area Code
CityAreaCode
(202)
CY2022 dei Local Phone Number
LocalPhoneNumber
656-4257
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
232760000
CY2022 dei Auditor Firm
AuditorFirmId
1596
CY2022 dei Auditor Name
AuditorName
Frank, Rimerman + Co. LLP
CY2022 dei Auditor Location
AuditorLocation
San Francisco, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116320
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
740639
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
322292
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
826171
CY2022Q4 us-gaap Assets Current
AssetsCurrent
438612
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1566810
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
237796114
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
234618998
CY2022Q4 us-gaap Assets
Assets
238234726
CY2021Q4 us-gaap Assets
Assets
236185808
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27056
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5433
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
116306
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32489
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
116306
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1431546
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1053556
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2547235
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
27056
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11500980
CY2022Q4 CBRGU Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
267420
CY2021Q4 CBRGU Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
267420
CY2022Q4 us-gaap Liabilities
Liabilities
4278690
CY2021Q4 us-gaap Liabilities
Liabilities
12938262
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3740653
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11353029
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3740078
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-11352454
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
238234726
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236185808
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1094381
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
188696
CY2022 CBRGU General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
300000
CBRGU General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
30000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1394381
us-gaap Operating Income Loss
OperatingIncomeLoss
-218696
CY2022 CBRGU Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-8953745
CBRGU Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-5312940
CY2022 CBRGU Change In Fair Value Of Convertible Note Related Party
ChangeInFairValueOfConvertibleNoteRelatedParty
27990
CBRGU Change In Fair Value Of Convertible Note Related Party
ChangeInFairValueOfConvertibleNoteRelatedParty
-96444
CBRGU Offering Cost Derivative Warrant Liabilities
OfferingCostDerivativeWarrantLiabilities
253876
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3177116
us-gaap Investment Income Interest
InvestmentIncomeInterest
18998
CY2022 us-gaap Net Income Loss
NetIncomeLoss
10708490
us-gaap Net Income Loss
NetIncomeLoss
4955810
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2476080
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
18809344
us-gaap Net Income Loss
NetIncomeLoss
4955810
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-11352454
CY2022 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
3096114
CY2022 us-gaap Net Income Loss
NetIncomeLoss
10708490
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3740078
CY2022 us-gaap Profit Loss
ProfitLoss
10708490
us-gaap Profit Loss
ProfitLoss
4955810
CBRGU General And Administrative Expenses Paid By Initial Shareholders In Exchange For Issuance Of Founder Shares
GeneralAndAdministrativeExpensesPaidByInitialShareholdersInExchangeForIssuanceOfFounderShares
18450
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
15175
CY2022 CBRGU Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-8953745
CBRGU Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-5312940
CY2022 CBRGU Change In Fair Value Of Convertible Note Related Party
ChangeInFairValueOfConvertibleNoteRelatedParty
27990
CBRGU Offering Cost Derivative Warrant Liabilities
OfferingCostDerivativeWarrantLiabilities
253876
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3177116
us-gaap Investment Income Interest
InvestmentIncomeInterest
18998
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-503879
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
826171
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-40873
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46306
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-904319
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-868492
CBRGU Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
234600000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-234600000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4150
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
350000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1053556
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
243565
CBRGU Net Proceeds From Initial Public Offering
NetProceedsFromInitialPublicOffering
230000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10550000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
70000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5155010
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
280000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
236209131
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-624319
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
740639
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740639
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116320
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740639
CBRGU Deferred Offering Cost Included In Accrued Expenses
DeferredOfferingCostIncludedInAccruedExpenses
70000
CBRGU Deferred Offering Cost Paid By Related Party Towards Issuance Of Promissory Note
DeferredOfferingCostPaidByRelatedPartyTowardsIssuanceOfPromissoryNote
228390
CBRGU Prepaid Expenses And Deferred Offering Cost Paid By Sponsor Towards Issuance Of Common Stock
PrepaidExpensesAndDeferredOfferingCostPaidBySponsorTowardsIssuanceOfCommonStock
2400
CBRGU Deferred Legal Fees
DeferredLegalFees
267420
CY2022 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
3096114
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 — Description of Organization and Business Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Chain Bridge I (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on partnering with a technology company that will advance U.S. national security and intelligence interests. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not yet commenced operations. All activity for the period from January 21, 2021 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and since the closing of the Initial Public Offering, the search for a prospective Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s sponsor is Chain Bridge Group, a Cayman Islands exempted limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 9, 2021. On November 15, 2021, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”),  at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $5.7 million, of which approximately $254,000 was for offering costs allocated to derivative warrant liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 10,550,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant to the Sponsor and CB Co-Investment LLC (“CB Co-Investment”), generating proceeds of approximately $10.6 million (Note 4).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, upon closing of the Initial Public Offering, CB Co-Investment loaned the Company $1,150 thousand at no interest (the “CB Co-Investment Loan”). On November 16, 2022, the Sponsor agreed to loan the Company up to $1,200 thousand pursuant to an unsecured non-interest bearing convertible promissory note (“Additional Convertible Note”). Such Additional Convertible Note will not be repaid in the event that the Company is unable to close a Business Combination unless there are funds available outside the Trust Account to do so. Such Additional Convertible Note would either be paid upon consummation of the Company’s initial Business Combination, or, at the discretion of Sponsor, converted into additional warrants at a price of $1.00 per warrant, which warrants will be identical to the Private Placement Warrants. As of December 31, 2022, the Company had drawn $350,000 under this Additional Convertible Note. (Note 5).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering, $234.6 million ($10.20 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering, certain of the proceeds of the Private Placement and the proceeds from the convertible promissory note issued to CB Co-Investment, were placed in a trust account (“Trust Account”) with Continental Stock Transfer &amp; Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants and the proceeds from the promissory note issued to CB Co-Investment, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair value equal to at least 80% of the net assets held in the Trust Account (excluding taxes payable on the interest earned on the trust account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the partner business or otherwise acquires a controlling interest in the partner business sufficient for it not to be required to register as an investment company under the Investment Company Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. The Company expects the pro rata redemption price to be $10.20 per share (such amount may be increased by $0.10 per Public Share for each three-month extension of the time to consummate the initial Business Combination, as described below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the Amended and Restated Memorandum and Articles of Association, which was adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether they were a Public Shareholder on the record date for the general meeting held to approve the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this Initial Public Offering (the “Initial Shareholders”), and the executive officers and directors of the Company, agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has 18 months from the closing of the Initial Public Offering to consummate an initial Business Combination. However, if the Company anticipates that it may not be able to consummate the initial Business Combination within 18 months, the Company may, by resolution of its board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to two times, each by an additional three months (for a total of up to 24 months to complete a Business Combination), subject to the Sponsor and/or its affiliates or designees) depositing into the Trust Account, on or prior to the applicable deadline, additional funds of $0.10 per Public Share, $2.3 million in the aggregate, for each of the available three-month extensions, for a total payment of up to $4.0 million, or up to $4.6 million if the underwriters’ over-allotment option is exercised in full ($0.20 per Public Share in either case). Any such payments would be made in the form of non-interest bearing loans. The Public Shareholders will not be entitled to vote or redeem their shares in connection with any such extension.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s Sponsor, officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Initial Public Offering (or within up to 24 months if the Company extends the period of time) or (B) with respect to any other provisions relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">If the Company is unable to complete a Business Combination within 18 months, or May 15, 2023, (or within up to 24 months if the Company extends the period of time) (the “Combination Period”), the Company will (i) cease all operations except for the purpose </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">of winding up; (ii) as promptly as reasonably possible, but not more than <span style="-sec-ix-hidden:Hidden_DIRT52kJFEixZz0qV-6qzQ;"><span style="-sec-ix-hidden:Hidden_RNPACPB8VUOBCwNtO3hAmQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span></span> business days thereafter, redeem the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution expenses).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:18pt;margin:0pt;">The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the Marketing Fee (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution in the Trust Account will be less than the $10.20 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective partner business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective partner business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective partner businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. There can be no guarantee that the Company will be successful in obtaining such waivers from its targeted vendors and service providers.<span style="font-style:italic;font-weight:bold;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Emerging Growth Company</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risks and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management continues to evaluate the impact of the COVID-19 pandemic, including new variant strains of the underlying virus, current or anticipated military conflict, including between Russia and Ukraine, terrorism, sanctions or other geopolitical events as well as adverse developments in the economy and capital markets, including rising energy costs, inflation and interest rates, in the United States and globally, on the industry and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Going Concern</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had approximately $116,000 in its operating bank account and working capital of approximately $406,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor and CB Co-Investment to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5) and a loan from related party of approximately $244,000. The Company fully repaid the Note on November 17, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, the Private Placement held outside of the Trust Account and the issuance of the Convertible Notes. As of December 31, 2022 and 2021, there was $1,500,000 and $1,150,000, respectively, outstanding under the working capital loans (convertible notes).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with our assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about its ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 15, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. Management plans to complete a business combination prior to the mandatory liquidation date (including any extensions as needed).</p>
CY2022 CBRGU Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2022 CBRGU Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2022 CBRGU Threshold Minimum Aggregate Fair Market Value As Percentage Of Net Asset Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetHeldInTrustAccount
0.80
CY2022 CBRGU Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination
ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
0.50
CY2022 CBRGU Class Of Warrant Or Right Pro Rata Redemption Price Of Warrants Or Rights
ClassOfWarrantOrRightProRataRedemptionPriceOfWarrantsOrRights
10.20
CY2022 CBRGU Class Of Warrant Or Right Increase In Pro Rata Redemption Price Of Warrants Or Rights
ClassOfWarrantOrRightIncreaseInProRataRedemptionPriceOfWarrantsOrRights
0.10
CY2022 CBRGU Additional Extension Period To Consummate Business Combination
AdditionalExtensionPeriodToConsummateBusinessCombination
P3M
CY2022Q4 CBRGU Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001
CY2022 CBRGU Threshold Percentage Of Public Shares Subject To Redemption Without Company Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent
0.15
CY2022 CBRGU Period To Consummate Initial Business Combination
PeriodToConsummateInitialBusinessCombination
P18M
CY2022 CBRGU Period To Consummate Initial Business Combination
PeriodToConsummateInitialBusinessCombination
P18M
CY2022 CBRGU Number Additional Extension To Business Combination Consummate Period
NumberAdditionalExtensionToBusinessCombinationConsummatePeriod
2
CY2022 CBRGU Additional Extension Period To Consummate Business Combination
AdditionalExtensionPeriodToConsummateBusinessCombination
P3M
CY2022 CBRGU Maximum Period To Consummate Initial Business Combination
MaximumPeriodToConsummateInitialBusinessCombination
P24M
CY2022 CBRGU Share Price For Additional Extension Business Combination Consummate Period
SharePriceForAdditionalExtensionBusinessCombinationConsummatePeriod
0.10
CY2022Q4 CBRGU Fund Due Per Additional Extension To Business Combination Consummate Period
FundDuePerAdditionalExtensionToBusinessCombinationConsummatePeriod
2300000
CY2022 CBRGU Additional Extension Period To Consummate Business Combination
AdditionalExtensionPeriodToConsummateBusinessCombination
P3M
CY2022Q4 CBRGU Aggregate Fund Due For Additional Extension To Business Combination Consummate Period
AggregateFundDueForAdditionalExtensionToBusinessCombinationConsummatePeriod
4000000.0
CY2022 CBRGU Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2022 CBRGU Period To Consummate Initial Business Combination
PeriodToConsummateInitialBusinessCombination
P18M
CY2022 CBRGU Maximum Period To Consummate Initial Business Combination
MaximumPeriodToConsummateInitialBusinessCombination
P24M
CY2022 CBRGU Period To Consummate Initial Business Combination
PeriodToConsummateInitialBusinessCombination
P18M
CY2022 CBRGU Maximum Period To Consummate Initial Business Combination
MaximumPeriodToConsummateInitialBusinessCombination
P24M
CY2022 CBRGU Maximum Net Interest To Pay Dissolution Expenses
MaximumNetInterestToPayDissolutionExpenses
100000
CY2022 CBRGU Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2022 CBRGU Maximum Net Interest To Pay Dissolution Expenses
MaximumNetInterestToPayDissolutionExpenses
100000
CY2022 CBRGU Operating Bank Accounts
OperatingBankAccounts
116000
CY2022 CBRGU Working Capital
WorkingCapital
406000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of </i><i style="font-style:italic;letter-spacing:-0.05pt;">Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The<span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">preparation</span><span style="letter-spacing:0.4pt;"> </span>of<span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">financial</span><span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">statements</span><span style="letter-spacing:0.45pt;"> </span>in<span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">conformity</span><span style="letter-spacing:0.45pt;"> </span>with<span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">GAAP</span><span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">requires</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">management</span><span style="letter-spacing:0.45pt;"> </span>to<span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">make</span><span style="letter-spacing:0.5pt;"> </span><span style="letter-spacing:-0.05pt;">estimates</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">and</span><span style="letter-spacing:5.25pt;"> </span><span style="letter-spacing:-0.05pt;">assumptions</span><span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">that</span><span style="letter-spacing:-0.2pt;"> </span>affect<span style="letter-spacing:-0.2pt;"> </span>the<span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">reported</span><span style="letter-spacing:-0.15pt;"> </span><span style="letter-spacing:-0.05pt;">amounts</span><span style="letter-spacing:-0.2pt;"> </span>of<span style="letter-spacing:-0.15pt;"> </span><span style="letter-spacing:-0.05pt;">assets</span><span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">and</span><span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">liabilities</span><span style="letter-spacing:-0.2pt;"> </span>and<span style="letter-spacing:-0.15pt;"> </span><span style="letter-spacing:-0.05pt;">disclosure</span><span style="letter-spacing:-0.2pt;"> </span>of<span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">contingent</span><span style="letter-spacing:-0.2pt;"> </span><span style="letter-spacing:-0.05pt;">assets</span><span style="letter-spacing:-0.25pt;"> </span>and<span style="letter-spacing:-0.15pt;"> </span><span style="letter-spacing:-0.05pt;">liabilities</span><span style="letter-spacing:6.15pt;"> </span>at<span style="letter-spacing:0.2pt;"> </span>the<span style="letter-spacing:0.15pt;"> </span>date<span style="letter-spacing:0.15pt;"> </span>of<span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:0.2pt;"> </span>financial<span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">statements</span><span style="letter-spacing:0.25pt;"> </span><span style="letter-spacing:-0.05pt;">and</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">reported</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">amounts</span><span style="letter-spacing:0.15pt;"> </span>of<span style="letter-spacing:0.25pt;"> </span><span style="letter-spacing:-0.05pt;">income</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">and</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">expenses</span><span style="letter-spacing:0.1pt;"> </span><span style="letter-spacing:-0.05pt;">during</span><span style="letter-spacing:0.2pt;"> </span>the<span style="letter-spacing:0.15pt;"> </span><span style="letter-spacing:-0.05pt;">reporting</span><span style="letter-spacing:0.2pt;"> </span><span style="letter-spacing:-0.05pt;">period.</span><span style="letter-spacing:5.05pt;"> </span><span style="letter-spacing:-0.05pt;">Making</span><span style="letter-spacing:0.95pt;"> </span><span style="letter-spacing:-0.05pt;">estimates</span><span style="letter-spacing:0.95pt;"> </span><span style="letter-spacing:-0.05pt;">requires</span><span style="letter-spacing:0.95pt;"> </span><span style="letter-spacing:-0.05pt;">management</span><span style="letter-spacing:0.9pt;"> </span>to<span style="letter-spacing:0.8pt;"> </span><span style="letter-spacing:-0.05pt;">exercise</span><span style="letter-spacing:0.85pt;"> </span><span style="letter-spacing:-0.05pt;">significant</span><span style="letter-spacing:0.95pt;"> </span><span style="letter-spacing:-0.05pt;">judgment.</span><span style="letter-spacing:0.95pt;"> </span>It<span style="letter-spacing:0.9pt;"> </span>is<span style="letter-spacing:0.9pt;"> </span>at<span style="letter-spacing:0.9pt;"> </span><span style="letter-spacing:-0.05pt;">least</span><span style="letter-spacing:0.85pt;"> </span><span style="letter-spacing:-0.05pt;">reasonably</span><span style="letter-spacing:0.9pt;"> </span><span style="letter-spacing:-0.05pt;">possible</span><span style="letter-spacing:0.9pt;"> </span>that<span style="letter-spacing:0.9pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:5.85pt;"> </span><span style="letter-spacing:-0.05pt;">estimate</span><span style="letter-spacing:-0.5pt;"> </span>of<span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:-0.6pt;"> </span>effect<span style="letter-spacing:-0.6pt;"> </span>of<span style="letter-spacing:-0.55pt;"> </span>a<span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">condition,</span><span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">situation</span><span style="letter-spacing:-0.5pt;"> </span>or<span style="letter-spacing:-0.45pt;"> </span>set<span style="letter-spacing:-0.55pt;"> </span>of<span style="letter-spacing:-0.55pt;"> </span><span style="letter-spacing:-0.05pt;">circumstances</span><span style="letter-spacing:-0.55pt;"> </span>that<span style="letter-spacing:-0.55pt;"> </span><span style="letter-spacing:-0.05pt;">existed</span><span style="letter-spacing:-0.55pt;"> </span>at<span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">date</span><span style="letter-spacing:-0.5pt;"> </span>of<span style="letter-spacing:-0.55pt;"> </span>the<span style="letter-spacing:-0.55pt;"> </span><span style="letter-spacing:-0.05pt;">financial</span><span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">statements,</span><span style="letter-spacing:5.05pt;"> </span><span style="letter-spacing:-0.05pt;">which</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">management</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">considered</span><span style="letter-spacing:0.5pt;"> </span><span style="letter-spacing:-0.05pt;">in</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">formulating</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">its</span><span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">estimate,</span><span style="letter-spacing:0.35pt;"> </span><span style="letter-spacing:-0.05pt;">could</span><span style="letter-spacing:0.5pt;"> </span><span style="letter-spacing:-0.05pt;">change</span><span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">in</span><span style="letter-spacing:0.5pt;"> </span><span style="letter-spacing:-0.05pt;">the</span><span style="letter-spacing:0.45pt;"> </span>near<span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">term</span><span style="letter-spacing:0.4pt;"> </span>due<span style="letter-spacing:0.4pt;"> </span>to<span style="letter-spacing:0.4pt;"> </span>one<span style="letter-spacing:0.4pt;"> </span>or<span style="letter-spacing:0.45pt;"> </span><span style="letter-spacing:-0.05pt;">more</span><span style="letter-spacing:0.4pt;"> </span><span style="letter-spacing:-0.05pt;">future</span><span style="letter-spacing:5.05pt;"> </span><span style="letter-spacing:-0.05pt;">confirming</span> <span style="letter-spacing:-0.05pt;">events.</span> <span style="letter-spacing:-0.05pt;">Accordingly,</span> the<span style="letter-spacing:-0.05pt;"> </span>actual<span style="letter-spacing:-0.1pt;"> </span><span style="letter-spacing:-0.05pt;">results</span> <span style="letter-spacing:-0.05pt;">could</span> <span style="letter-spacing:-0.05pt;">differ significantly</span> from <span style="letter-spacing:-0.05pt;">those</span> <span style="letter-spacing:-0.05pt;">estimates.</span></p>
CY2022 CBRGU Threshold Period For Filling Registration Statement After Business Combination
ThresholdPeriodForFillingRegistrationStatementAfterBusinessCombination
P20D
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;letter-spacing:-0.05pt;">Concentration </i><i style="font-style:italic;">of Credit</i><i style="font-style:italic;letter-spacing:-0.05pt;"> </i><i style="font-style:italic;">Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0pt 0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="letter-spacing:-0.05pt;">Financial</span><span style="letter-spacing:1.95pt;"> </span><span style="letter-spacing:-0.05pt;">instruments</span><span style="letter-spacing:1.95pt;"> </span>that<span style="letter-spacing:1.85pt;"> </span><span style="letter-spacing:-0.05pt;">potentially</span><span style="letter-spacing:1.95pt;"> </span><span style="letter-spacing:-0.05pt;">subject</span><span style="letter-spacing:1.9pt;"> </span>the<span style="letter-spacing:1.95pt;"> </span><span style="letter-spacing:-0.05pt;">Company</span><span style="letter-spacing:1.95pt;"> </span>to<span style="letter-spacing:1.95pt;"> </span><span style="letter-spacing:-0.05pt;">concentrations</span><span style="letter-spacing:1.9pt;"> </span>of<span style="letter-spacing:1.95pt;"> </span><span style="letter-spacing:-0.05pt;">credit</span><span style="letter-spacing:1.95pt;"> </span>risk<span style="letter-spacing:2pt;"> </span><span style="letter-spacing:-0.05pt;">consist</span><span style="letter-spacing:1.95pt;"> </span>of<span style="letter-spacing:2pt;"> </span><span style="letter-spacing:-0.05pt;">cash</span><span style="letter-spacing:5.05pt;"> </span>accounts<span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">in</span><span style="letter-spacing:0.35pt;"> </span>a<span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">financial</span><span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">institution,</span><span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">which,</span><span style="letter-spacing:0.3pt;"> </span>at<span style="letter-spacing:0.25pt;"> </span><span style="letter-spacing:-0.05pt;">times,</span><span style="letter-spacing:0.35pt;"> </span><span style="letter-spacing:-0.05pt;">may</span><span style="letter-spacing:0.35pt;"> </span><span style="letter-spacing:-0.05pt;">exceed</span><span style="letter-spacing:0.35pt;"> </span>the<span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">Federal</span><span style="letter-spacing:0.3pt;"> </span>Deposit<span style="letter-spacing:0.3pt;"> </span><span style="letter-spacing:-0.05pt;">Insurance</span><span style="letter-spacing:0.55pt;"> </span><span style="letter-spacing:-0.05pt;">Corporation</span><span style="letter-spacing:0.35pt;"> (“FDIC”) </span><span style="letter-spacing:-0.05pt;">coverage</span><span style="letter-spacing:5.55pt;"> </span><span style="letter-spacing:-0.05pt;">limit</span><span style="letter-spacing:-0.45pt;"> </span>of<span style="letter-spacing:-0.45pt;"> </span><span style="letter-spacing:-0.05pt;">$250,000.</span><span style="letter-spacing:-0.45pt;"> </span><span style="letter-spacing:-0.05pt;">The</span><span style="letter-spacing:-0.45pt;"> </span><span style="letter-spacing:-0.05pt;">Company</span><span style="letter-spacing:-0.5pt;"> </span>has<span style="letter-spacing:-0.45pt;"> </span>not<span style="letter-spacing:-0.45pt;"> </span><span style="letter-spacing:-0.05pt;">experienced</span><span style="letter-spacing:-0.4pt;"> </span><span style="letter-spacing:-0.05pt;">losses</span><span style="letter-spacing:-0.5pt;"> </span>on<span style="letter-spacing:-0.4pt;"> </span>these<span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">accounts</span><span style="letter-spacing:-0.4pt;"> </span><span style="letter-spacing:-0.05pt;">and</span><span style="letter-spacing:-0.4pt;"> </span><span style="letter-spacing:-0.05pt;">management</span><span style="letter-spacing:-0.5pt;"> </span><span style="letter-spacing:-0.05pt;">believes</span><span style="letter-spacing:-0.45pt;"> </span>the<span style="letter-spacing:-0.45pt;"> </span><span style="letter-spacing:-0.05pt;">Company</span><span style="letter-spacing:5.25pt;"> </span>is <span style="letter-spacing:-0.05pt;">not</span> <span style="letter-spacing:-0.05pt;">exposed</span><span style="letter-spacing:-0.1pt;"> </span>to <span style="letter-spacing:-0.05pt;">significant</span> <span style="letter-spacing:-0.05pt;">risks </span>on <span style="letter-spacing:-0.05pt;">such</span> <span style="letter-spacing:-0.05pt;">accounts.</span></p>
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
22050000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2022 CBRGU Restrictions On Transfer Period Of Time After Business Combination Completion
RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
P1Y
CY2022 CBRGU Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
P20D
CY2022 CBRGU Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
P30D
CY2022 CBRGU Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences
ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
P150D
CY2022 CBRGU Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
P20D
CY2022 CBRGU Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
P30D
CY2022 CBRGU Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences
ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
P150D
CY2022 CBRGU Period To Consummate Initial Business Combination
PeriodToConsummateInitialBusinessCombination
P18M
CY2022Q4 CBRGU Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 CBRGU Convertible Stock Conversion Ratio
ConvertibleStockConversionRatio
1
CY2022 CBRGU Threshold Period For Filling Registration Statement Within Number Of Days Of Business Combination
ThresholdPeriodForFillingRegistrationStatementWithinNumberOfDaysOfBusinessCombination
P60D
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q4 us-gaap Share Price
SharePrice
9.20
CY2022Q4 CBRGU Percentage Of Gross Proceeds On Total Equity Proceeds
PercentageOfGrossProceedsOnTotalEquityProceeds
0.60
CY2022 CBRGU Threshold Number Of Specified Trading Days Determining Volume Weighted Average Trading Price
ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice
P10D
CY2022Q4 us-gaap Share Price
SharePrice
9.20
CY2022Q4 CBRGU Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value
ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValue
1.15
CY2022Q4 CBRGU Class Of Warrant Or Right Redemption Of Warrants Or Rights Reference Price
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice
18.00
CY2022Q4 CBRGU Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValue
1.80
CY2022 CBRGU Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination
ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
P30D
CY2022Q4 us-gaap Cash
Cash
315
CY2021Q4 us-gaap Cash
Cash
344

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001104659-23-033841-index-headers.html Edgar Link pending
0001104659-23-033841-index.html Edgar Link pending
0001104659-23-033841.txt Edgar Link pending
0001104659-23-033841-xbrl.zip Edgar Link pending
cbrgu-20221231.xsd Edgar Link pending
cbrgu-20221231x10k.htm Edgar Link pending
cbrgu-20221231xex10d6.htm Edgar Link pending
cbrgu-20221231xex31d1.htm Edgar Link pending
cbrgu-20221231xex31d2.htm Edgar Link pending
cbrgu-20221231xex32d1.htm Edgar Link pending
cbrgu-20221231xex32d2.htm Edgar Link pending
cbrgu-20221231xex4d5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cbrgu-20221231_cal.xml Edgar Link unprocessable
cbrgu-20221231_def.xml Edgar Link unprocessable
cbrgu-20221231_lab.xml Edgar Link unprocessable
cbrgu-20221231x10k_htm.xml Edgar Link completed
cbrgu-20221231_pre.xml Edgar Link unprocessable